2cureX's IPO

2cureX raised a round of funding on November 24, 2017. Investors include Public.

2cureX is a biotech company with a vision to improve treatment efficiency of cancer patients. The company has developed the IndiTreat method, an in-vitro test specialized in identifying and matching t…

Articles about 2cureX's IPO: